The prognosis valve of tumor regression grade in the same ypStage patients after neoadjuvant treatment in locally advanced rectal cancer: Post-hoc analysis of a prospective trial. This is an ASCO ...
MEMPHIS, Tenn., Nov. 19, 2015 /PRNewswire/ -- Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now ...
Hapten Sciences and Particle Sciences are working together to move Hapten’s poison ivy, oak, and sumac therapy into clinical trials. According to Memphis-based Hapten, its injectable small-molecule ...
Highly Active Antiretroviral Therapy in AIDS-Associated Kaposi's Sarcoma: Implications for the Design of Therapeutic Trials in Patients With Advanced, Symptomatic Kaposi's Sarcoma Two hundred fourteen ...
How do haptens elicit an immune response? Unlike antigens, haptens require an additional molecule before they are able to elicit an immune response. These additional molecules are called “carriers” ...
Targeted therapies and immunotherapies have revolutionized cancer treatment in recent years. However, achieving durable responses and, ultimately, curing metastatic cancers driven by intracellular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results